Dermatology · Spring, TX
NPI
1619950383
Since 2005
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
28517 Spring Trails Ridge, 110
Spring, TX, 77386
Phone (281) 385-8189
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
1,992 services
Medicare patients, 2024
390
Average age 74
Drug cost, 2024
$762K
1,535 prescriptions
Company payments, 2025
$5,017
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Temitope F Soares was code 17003 (destruction skin lesion), 626 times for 81 patients. In total Temitope F Soares billed 1,992 services in 56 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 626 | 81 | $4.74 | $2,964 |
| 99213 Office E&M - Established | Office | 289 | 207 | $57.75 | $17K |
| 99214 Office E&M - Established | Office | 169 | 126 | $79.14 | $13K |
| 17000 Destruction Skin Lesion | Office | 123 | 102 | $38.34 | $4,716 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 86 | 12 | $0.77 | $66.25 |
| 11303 Removal or Shaving of Skin Growth | Office | 71 | 59 | $89.59 | $6,361 |
| 99203 Office E&M - New | Office | 70 | 70 | $55.13 | $3,859 |
| 17110 Destruction Skin Lesion | Office | 59 | 51 | $71.16 | $4,199 |
| 11312 Removal or Shaving of Skin Growth | Office | 49 | 42 | $92.62 | $4,538 |
| 11302 Removal or Shaving of Skin Growth | Office | 47 | 41 | $73.33 | $3,447 |
| 99212 Office E&M - Established | Office | 31 | 29 | $40.07 | $1,242 |
| 11313 Removal or Shaving of Skin Growth | Office | 27 | 25 | $123.82 | $3,343 |
| 99204 Office E&M - New | Office | 25 | 25 | $106.36 | $2,659 |
| 11307 Removal or Shaving of Skin Growth | Office | 22 | 21 | $67.55 | $1,486 |
| 11104 Skin Biopsy | Office | 22 | 22 | $78.48 | $1,727 |
By year: 2022 $123K for 2,231 services; 2023 $143K for 2,312 services; 2024 $108K for 1,992 services.
Medicare prescription drug claims, 2024
In 2024, the drug Temitope F Soares prescribed most often to Medicare patients was Clobetasol Propionate, with 252 prescriptions and refills. In total Temitope F Soares wrote 1,535 Medicare prescriptions that cost $762K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 252 | 259 | 129 | $9,982 |
| Mupirocin Generic | 200 | 208 | 141 | $1,868 |
| Doxepin Hcl Generic | 118 | 125 | 50 | $1,972 |
| Cephalexin Generic | 113 | 113 | 95 | $561 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 104 | 104 | 88 | $326 |
| Fluocinonide Generic | 77 | 86 | 44 | $2,702 |
| Triamcinolone Acetonide Generic | 71 | 76 | 57 | $540 |
| Doxycycline Hyclate Generic | 65 | 75 | 32 | $1,166 |
| Prednisone Generic | 60 | 60 | 58 | $173 |
| Hydrocortisone Generic | 47 | 49 | 28 | $621 |
| Ketoconazole Generic | 43 | 46 | 24 | $551 |
| Dupixent Syringe Dupilumab | 38 | 38 | Under 11 | $142K |
| Terbinafine Hcl Generic | 26 | 26 | 12 | $294 |
| Tovet Emollient Clobetasol Propionate/Emoll | 25 | 25 | Under 11 | $10K |
| Humira(Cf) Pen Adalimumab | 21 | 21 | Under 11 | $148K |
Brand drugs: 146 claims; generic drugs: 1,389 claims; opioid claims: 116.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Temitope F Soares $5,017 ($5,017 in general payments such as food, travel and fees) from 18 companies. The largest payer was UCB, Inc. with $1,672.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 20 | $1,672 |
| Janssen Biotech, Inc. JNJ | 19 | $584 |
| Genzyme Corporation SNY | 10 | $359 |
| Abbvie Inc. ABBV | 16 | $337 |
| Lilly USA, LLC LLY | 17 | $287 |
| Arcutis Biotherapeutics, Inc. ARQT | 20 | $275 |
| Organon LLC OGN | 32 | $271 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $254 |
| Galderma Laboratories, L.P. GALD.SW | 9 | $219 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $208 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.